Skip to content
naulon
Not checkedNot checked for notices yet.

Relationship between Metabolic Syndrome and Inflammation in Peritoneal Dialysis Patients

A. Borazan, E. Ucar, M. Gursu and 2 more

European Journal of Inflammation · 2012

doi:10.1177/1721727x1201000205 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

We aimed to investigate the relationship between inflammation and metabolic syndrome as defined by the National Cholesterol Education Program Adults Treatment Panel III (NCEP-ATP III) diagnostic criteria in peritoneal dialysis patients. Ninety-four patients treated with peritoneal dialysis were included in the study. Patients’ age, sex, weight, waist circumference, arterial blood pressure, fasting blood glucose, total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, C-reactive protein, albumin, uric acid and fibrinogen levels were recorded. Fourty-one patients diagnosed with metabolic syndrome and 53 peritoneal dialysis patients without metabolic syndrome were identified. In the metabolic syndrome group mean decrease in serum albumin and mean increase in C-reactive protein and fibrinogen was significantly different from the other group (p<0.05, p<0.05, p<0.05, respectively). When gender, diabetes Mellitus, and hypertension status were evaluated, the difference was not significant (p> 0.05). Peritoneal dialysis patients with metabolic syndrome should also be assessed for inflammation.

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.